Given these conflicting reports, and the established primacy of the intestinal turnover in acute GVHD pathogenesis (13, 14, 42, 43), we aimed to determine the impact of PLX2853 BET inhibition on Lgr5+ intestinal stem cells. This evidence concerns the gene LGR5 and acute graft versus host disease.